APOKYN
USWM-AP1-4002
Approved small_molecule terminated
Quick answer
APOKYN for Parkinson's Disease is a Approved program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- SUPERNUS PHARMACEUTICALS, INC.
- Indication
- Parkinson's Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated